chr6-112130993-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001105206.3(LAMA4):​c.3943G>A​(p.Val1315Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,613,042 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00078 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 4 hom. )

Consequence

LAMA4
NM_001105206.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: -0.00800
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030601919).
BP6
Variant 6-112130993-C-T is Benign according to our data. Variant chr6-112130993-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 44380.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=4}. Variant chr6-112130993-C-T is described in Lovd as [Benign]. Variant chr6-112130993-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 119 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LAMA4NM_001105206.3 linkuse as main transcriptc.3943G>A p.Val1315Ile missense_variant 29/39 ENST00000230538.12
LOC107986633XR_001744299.2 linkuse as main transcriptn.439+14566C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LAMA4ENST00000230538.12 linkuse as main transcriptc.3943G>A p.Val1315Ile missense_variant 29/391 NM_001105206.3 A1

Frequencies

GnomAD3 genomes
AF:
0.000782
AC:
119
AN:
152078
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0166
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.00127
AC:
319
AN:
250794
Hom.:
3
AF XY:
0.00114
AC XY:
154
AN XY:
135518
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0155
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000618
Gnomad OTH exome
AF:
0.000981
GnomAD4 exome
AF:
0.000372
AC:
544
AN:
1460846
Hom.:
4
Cov.:
31
AF XY:
0.000377
AC XY:
274
AN XY:
726752
show subpopulations
Gnomad4 AFR exome
AF:
0.000419
Gnomad4 AMR exome
AF:
0.0000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00923
Gnomad4 SAS exome
AF:
0.000557
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000360
Gnomad4 OTH exome
AF:
0.00119
GnomAD4 genome
AF:
0.000782
AC:
119
AN:
152196
Hom.:
1
Cov.:
32
AF XY:
0.000927
AC XY:
69
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0166
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000883
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000663
Hom.:
0
Bravo
AF:
0.000710
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00117
AC:
142
Asia WGS
AF:
0.00808
AC:
28
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 05, 2012Variant classified as Uncertain Significance - Favor Benign. The Val1308Ile vari ant (LAMA4) has been identified in 2/46 chromosomes from an Asian population, 7/ 2334 chromosomes from the 1000 Genomes population, and 1/3738 chromosomes from a broad but clinically unspecified African American cohort (http://evs.gs.washing ton.edu/EVS, dbSNP rs70940811). Valine (Val) residue at position 1308 is not con served among mammals, suggesting that a change may be tolerated. Computational t ools (PolyPhen2, SIFT, AlignGVGD) also predict this change to be benign although their accuracy is unknown. In summary, this variant is more likely benign but additional information is needed to fully assess its clinical significance. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 16, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Dilated cardiomyopathy 1JJ Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 17, 2024- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioMar 23, 2018- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
7.7
DANN
Benign
0.72
DEOGEN2
Benign
0.015
T;T;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.73
T;.;.;T
MetaRNN
Benign
0.0031
T;T;T;T
MetaSVM
Benign
-0.97
T
MutationTaster
Benign
0.94
N;N;N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.48
N;N;N;N
REVEL
Benign
0.22
Sift
Benign
0.23
T;T;T;T
Sift4G
Benign
1.0
T;T;T;T
Vest4
0.12
MVP
0.30
MPC
0.097
ClinPred
0.0038
T
GERP RS
-2.0
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs70940811; hg19: chr6-112452195; COSMIC: COSV57893577; COSMIC: COSV57893577; API